ATE516036T1 - Anwendung von alkylphosphocholinen in kombination mit antitumormedikamenten - Google Patents

Anwendung von alkylphosphocholinen in kombination mit antitumormedikamenten

Info

Publication number
ATE516036T1
ATE516036T1 AT03766336T AT03766336T ATE516036T1 AT E516036 T1 ATE516036 T1 AT E516036T1 AT 03766336 T AT03766336 T AT 03766336T AT 03766336 T AT03766336 T AT 03766336T AT E516036 T1 ATE516036 T1 AT E516036T1
Authority
AT
Austria
Prior art keywords
alkylphosphocholines
combination
application
antitumor drugs
antitumor
Prior art date
Application number
AT03766336T
Other languages
German (de)
English (en)
Inventor
Juergen Engel
Eckhard Guenther
Herbert Sindermann
Original Assignee
Fterna Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fterna Zentaris Gmbh filed Critical Fterna Zentaris Gmbh
Application granted granted Critical
Publication of ATE516036T1 publication Critical patent/ATE516036T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT03766336T 2002-07-30 2003-07-29 Anwendung von alkylphosphocholinen in kombination mit antitumormedikamenten ATE516036T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39961502P 2002-07-30 2002-07-30
PCT/EP2003/008346 WO2004012744A1 (de) 2002-07-30 2003-07-29 Anwendung von alkylphosphocholinen in kombination mit antitumormedikamenten

Publications (1)

Publication Number Publication Date
ATE516036T1 true ATE516036T1 (de) 2011-07-15

Family

ID=31495746

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03766336T ATE516036T1 (de) 2002-07-30 2003-07-29 Anwendung von alkylphosphocholinen in kombination mit antitumormedikamenten

Country Status (26)

Country Link
US (3) US8389497B2 (OSRAM)
EP (2) EP2301551A1 (OSRAM)
JP (1) JP2005535688A (OSRAM)
KR (3) KR20110102485A (OSRAM)
CN (1) CN1302780C (OSRAM)
AR (1) AR040717A1 (OSRAM)
AT (1) ATE516036T1 (OSRAM)
AU (2) AU2003253350B2 (OSRAM)
BR (1) BR0313048A (OSRAM)
CA (1) CA2493023C (OSRAM)
CY (1) CY1111902T1 (OSRAM)
DK (1) DK1545553T3 (OSRAM)
ES (1) ES2369535T3 (OSRAM)
HR (1) HRP20050184B1 (OSRAM)
IL (1) IL166329A (OSRAM)
MX (1) MXPA05001203A (OSRAM)
NO (1) NO335196B1 (OSRAM)
NZ (1) NZ538428A (OSRAM)
PL (1) PL375493A1 (OSRAM)
PT (1) PT1545553E (OSRAM)
RU (1) RU2005105693A (OSRAM)
SI (1) SI1545553T1 (OSRAM)
TW (1) TWI332007B (OSRAM)
UA (1) UA82322C2 (OSRAM)
WO (1) WO2004012744A1 (OSRAM)
ZA (1) ZA200500453B (OSRAM)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8383605B2 (en) 2002-07-30 2013-02-26 Aeterna Zentaris Gmbh Use of alkylphosphocholines in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals
AR040717A1 (es) 2002-07-30 2005-04-20 Zentaris Ag Uso de alquilfosfocolinas en cominacion con medicamentos antitumorales para el tratamiento de oncosis maligna y benigna en seres humanos y animales
DE10324911B4 (de) 2003-05-30 2005-08-18 Siemens Ag Röntgenvorrichtung mit partiellem digitalem Detektor und Verfahren zum Betrieb einer solchen
WO2006081452A2 (en) * 2005-01-28 2006-08-03 Robert Birch Co-administration of perifosine with chemotherapeutics
EP1800684A1 (en) * 2005-12-20 2007-06-27 Zentaris GmbH Novel alkyl phospholipid derivatives and uses thereof
UA99434C2 (ru) * 2005-12-19 2012-08-27 Аетерна Центаріс Гмбх Применение производных алкилфосфолипидов со сниженной цитотоксичностью
PL1962862T3 (pl) * 2005-12-19 2014-01-31 Aeterna Zentaris Gmbh Pochodne alkilofosfolipidów o ograniczonej cytotoksyczności i ich zastosowania
US8703179B2 (en) 2006-05-11 2014-04-22 Kimberly-Clark Worldwide, Inc. Mucosal formulation
AU2008282338B2 (en) * 2007-07-30 2015-02-12 Ardea Biosciences, Inc. Derivatives of N-(arylamino) sulfonamides including polymorphs as inhibitors of MEK as well as compositions, methods of use and methods for preparing the same
US20120128732A1 (en) * 2008-12-11 2012-05-24 Vuong Trieu Combinations and modes of administration of therapeutic agents and combination therapy
WO2011123691A1 (en) 2010-03-31 2011-10-06 Keryx Biopharmaceuticals, Inc. Perifosine and capecitabine as a combined treatment for cancer

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4219972A1 (de) * 1991-07-04 1993-01-07 Asta Medica Ag Arzneimittel mit antineoplastischer wirkung enthaltend als wirkstoff octadecyl-(2-(n-methylpiperidino)-ethyl)-phosphat und verfahren zu dessen herstellung
US5942639A (en) * 1991-07-04 1999-08-24 Asta Medica Aktiengesellschaft Process for the preparation of alkylphosphocholines and the production thereof in pure form
US6172050B1 (en) * 1992-07-11 2001-01-09 Asta Medica Aktiengesellschaft Phospholipid derivatives
JP3079993B2 (ja) * 1996-03-27 2000-08-21 日本電気株式会社 真空マイクロデバイスおよびその製造方法
DE19650778C2 (de) * 1996-12-06 2001-01-04 Asta Medica Ag Verwendung von Dopaminrezeptor-Antagonisten in der palliativen Tumortherapie
CN100413492C (zh) * 1998-01-22 2008-08-27 赞塔里斯有限公司 口服给药治疗利什曼病的含有米替福星的固体药物组合物
DE19959689A1 (de) * 1998-12-04 2000-06-08 Max Delbrueck Centrum Mittel zur Tumortherapie
DE69924146D1 (de) * 1998-12-21 2005-04-14 Inkeysa Sa Etherlysophospholipide zur behandlung von chronischen entzündlichen erkrankungen
EP2762140B1 (en) * 2001-02-19 2017-03-22 Novartis AG Treatment of solid brain tumours with a rapamycin derivative
KR20040018341A (ko) * 2001-03-23 2004-03-03 샤이어 바이오켐 인코포레이티드 암치료용 약제 조성물
WO2003005522A1 (es) 2001-07-04 2003-01-16 Acuna Arturo Tapones para sellado de ductos para redes electricas, telefonicas y de fibra optica.
PL371179A1 (en) * 2002-01-02 2005-06-13 Pharmacia Italia S.P.A. Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors
AR040717A1 (es) 2002-07-30 2005-04-20 Zentaris Ag Uso de alquilfosfocolinas en cominacion con medicamentos antitumorales para el tratamiento de oncosis maligna y benigna en seres humanos y animales
WO2005000318A2 (en) * 2003-06-23 2005-01-06 Neopharm, Inc. Method of inducing apoptosis and inhibiting cardiolipin synthesis
WO2006081452A2 (en) 2005-01-28 2006-08-03 Robert Birch Co-administration of perifosine with chemotherapeutics
UA99434C2 (ru) * 2005-12-19 2012-08-27 Аетерна Центаріс Гмбх Применение производных алкилфосфолипидов со сниженной цитотоксичностью
WO2011123691A1 (en) 2010-03-31 2011-10-06 Keryx Biopharmaceuticals, Inc. Perifosine and capecitabine as a combined treatment for cancer

Also Published As

Publication number Publication date
US20040097470A1 (en) 2004-05-20
HRP20050184A2 (en) 2005-04-30
SI1545553T1 (sl) 2011-09-30
RU2005105693A (ru) 2005-07-10
ES2369535T3 (es) 2011-12-01
EP2301551A1 (de) 2011-03-30
US8551977B2 (en) 2013-10-08
HK1080751A1 (en) 2006-05-04
KR20110102485A (ko) 2011-09-16
ZA200500453B (en) 2005-08-31
AR040717A1 (es) 2005-04-20
KR20130016413A (ko) 2013-02-14
HRP20050184B1 (hr) 2014-04-11
PL375493A1 (en) 2005-11-28
IL166329A0 (en) 2006-01-15
EP1545553B1 (de) 2011-07-13
PT1545553E (pt) 2011-09-12
IL166329A (en) 2012-08-30
KR20050026028A (ko) 2005-03-14
US20100189784A1 (en) 2010-07-29
EP1545553A1 (de) 2005-06-29
BR0313048A (pt) 2005-06-14
CN1671397A (zh) 2005-09-21
JP2005535688A (ja) 2005-11-24
CA2493023C (en) 2012-01-31
US8507710B2 (en) 2013-08-13
NO335196B1 (no) 2014-10-20
MXPA05001203A (es) 2005-06-08
AU2003253350B2 (en) 2008-06-26
TWI332007B (en) 2010-10-21
CY1111902T1 (el) 2015-11-04
AU2003253350A1 (en) 2004-02-23
NO20051040L (no) 2005-02-25
US8389497B2 (en) 2013-03-05
WO2004012744A1 (de) 2004-02-12
CA2493023A1 (en) 2004-02-12
NZ538428A (en) 2006-09-29
UA82322C2 (uk) 2008-04-10
KR101066804B1 (ko) 2011-09-22
AU2008203060A1 (en) 2008-07-31
AU2008203060B2 (en) 2011-04-21
US20100190738A1 (en) 2010-07-29
CN1302780C (zh) 2007-03-07
TW200404073A (en) 2004-03-16
DK1545553T3 (da) 2011-09-12

Similar Documents

Publication Publication Date Title
ATE405310T1 (de) Verbesserungen an antriebsmechanismen mit anwendung in verabreichungsvorrichtungen
CY2018009I1 (el) Παραλλαγες ανοσοσφαιρινων και χρησεις αυτων
DE602004004953D1 (de) Kochfeld mit Benutzerschnittstelle und beliebiger Positionierung
CY2014037I2 (el) C-met διαμορφωτες και μεθοδοι χρησης
IS7894A (is) Skammtaform með ofnæmisvaka
DE60238894D1 (de) Beleuchtungssystem und dessen Verwendung in Projektionssystem
NO20035645L (no) Forsterket medikamentlevering i transdermale systemer
DE60214640D1 (de) Mikroprozessor mit verbesserten Taskverwaltungs- und Tabellenverwaltungsvorrichtungen
CY2012024I1 (el) Υπο-ακετυλιωμενα και υπερ-ακετυλιωμενα μηνιγγοκοκκικα καψικα σακχαριδια
DE60326611D1 (de) N und dergleichen
DE602005003478D1 (de) Mit umfaltreitern versehene zettel und fahnen
EE200200607A (et) 2-atsüülindoolderivaadid ja nende kasutamine kasvajavastaste ravimitena
DE10294402D2 (de) Estrogen-Gestagen Kombinationspräparat und Anwendung
DE50213460D1 (de) Spirocyclische 3-phenyl-3-substituierte-4-ketolaktame und -laktone
ATE516036T1 (de) Anwendung von alkylphosphocholinen in kombination mit antitumormedikamenten
EE200300473A (et) Tsüano-asendatud dihüdropürimidiinühendid ja nende kasutamine haiguste raviks
DE60225159D1 (de) Substituierte benzimidazole und ihre anwendung in der krebsbehandlung
DE602004029478D1 (de) Echtzeit-on-line-wahrnehmung und kontrolle von emulsionen in formationsfluiden
EE200300474A (et) Tsüano-asendatud dihüdropürimidiinühendid ja nende kasutamine haiguste raviks
EP1478761A4 (en) DEGRADATION OF PESTICIDES AND HYDROPHOBIC ESTERIC TOXINS
PL361518A1 (pl) Zastosowanie substancji oraz kompozycja farmaceutyczna
EP1699270A4 (en) ORGANIC ELECTROLUMINESCENCE ELEMENT, CONDUCTIVE LAMINATE AND DISPLAY
DE602004022567D1 (de) Beleuchtungseinheit und projektor damit
EP1811320A4 (en) WHITE FILM AND BACKLIGHT USING THE SAME
EP1670755A4 (en) PYROVALERON ANALOGUE AND ITS THERAPEUTIC APPLICATIONS